Share Price and Basic Stock Data
Last Updated: December 24, 2025, 6:49 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bilcare Ltd, operating in the packaging and containers sector, reported a market capitalization of ₹191 Cr and a price per share of ₹81.3. The company’s revenue from operations for FY 2025 stood at ₹788 Cr, a slight increase from ₹747 Cr in FY 2024, but a decline from ₹982 Cr in FY 2023. Quarterly sales fluctuated throughout the year, with the highest sales of ₹255.69 Cr recorded in March 2022, declining to ₹174.94 Cr by December 2023. This trend indicates volatility in revenue generation, which may affect overall business stability. The trailing twelve months (TTM) revenue was reported at ₹757 Cr, suggesting a struggle to maintain consistent growth. The company has faced significant challenges in revenue generation, particularly evident in the decline from ₹845 Cr in FY 2022 to ₹747 Cr in FY 2024. This trend raises concerns about the company’s market positioning and competitiveness within the packaging sector.
Profitability and Efficiency Metrics
Bilcare Ltd reported a net profit of ₹-44 Cr, reflecting ongoing challenges in achieving profitability. The operating profit margin (OPM) for FY 2025 stood at 3.81%, consistent with the trend of low margins in recent years, as it declined from 7.34% in March 2022 to 5.38% in December 2024. The company’s interest coverage ratio (ICR) was reported at 0.76x, indicating that earnings are insufficient to cover interest expenses, a critical concern for sustainability. The return on equity (ROE) was recorded at 5.58%, while the return on capital employed (ROCE) was significantly lower at 1.10%, both reflecting inefficiencies in utilizing capital for generating profit. The net profit margin for FY 2025 was reported at -7.12%, emphasizing persistent challenges in translating revenue into profit, which could deter potential investors looking for stable returns.
Balance Sheet Strength and Financial Ratios
Bilcare Ltd’s balance sheet reveals a total debt of ₹672 Cr against reserves of ₹430 Cr, highlighting a concerning debt-to-equity ratio of 1.43x, which is substantially higher than typical sector standards. The company’s cash conversion cycle (CCC) was reported at 78 days, showing a relatively extended period to convert investments in inventory and accounts receivable back into cash. Additionally, the current ratio stood at 1.01x, indicating a marginal ability to cover short-term liabilities with current assets. The company reported a book value per share of ₹199.21 for FY 2025, which is significantly lower than the market price, suggesting undervaluation or potential financial distress. The enterprise value (EV) was recorded at ₹991.34 Cr, indicating that the market may be pricing in the risks associated with high leverage and low profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Bilcare Ltd reveals a stable promoter holding of 30.01%, while foreign institutional investors (FIIs) hold a negligible 0.04%. The public holds 69.94% of the shares, indicating a high level of retail investor participation. However, the number of shareholders has declined from 23,419 in December 2022 to 16,513 in September 2025, suggesting waning investor confidence. This decline may reflect concerns over the company’s financial performance and outlook. The lack of institutional investment could further exacerbate stock volatility and hinder capital inflow. The absence of dividend payouts reinforces the perception of financial instability, as investors typically seek returns on their investments. This shareholding structure, combined with the financial challenges faced, may lead to increased scrutiny from potential investors, impacting future fundraising efforts.
Outlook, Risks, and Final Insight
Looking ahead, Bilcare Ltd faces several risks that could impact its future performance. The company must navigate the competitive landscape of the packaging industry, where revenue volatility and profitability challenges persist. Additionally, high levels of debt relative to equity present significant financial risks, particularly in an environment of rising interest rates. Should the company successfully implement cost-cutting measures and improve operational efficiencies, it may stabilize its earnings and enhance investor confidence. Conversely, failure to address these issues could lead to further declines in market position and shareholder sentiment. Overall, Bilcare Ltd must focus on operational improvements and strategic initiatives to regain market traction and restore investor trust. The path forward will depend on effective management of both financial and operational challenges in the coming quarters.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Tin Works Ltd | 126 Cr. | 121 | 225/107 | 11.4 | 210 | 0.66 % | 7.95 % | 5.88 % | 10.0 |
| Gujarat Containers Ltd | 95.6 Cr. | 169 | 191/157 | 13.9 | 94.4 | 0.89 % | 18.4 % | 17.4 % | 10.0 |
| Goblin India Ltd | 15.5 Cr. | 11.2 | 34.5/10.3 | 20.9 | 32.8 | 0.00 % | 7.73 % | 4.63 % | 10.0 |
| G K P Printing & Packaging Ltd | 15.2 Cr. | 6.89 | 10.4/4.85 | 18.5 | 10.4 | 0.00 % | 4.87 % | 3.87 % | 10.0 |
| Garware Hi Tech Films Ltd | 7,391 Cr. | 3,184 | 5,375/2,317 | 23.6 | 1,079 | 0.38 % | 20.6 % | 15.0 % | 10.0 |
| Industry Average | 1,931.90 Cr | 322.14 | 48.49 | 189.19 | 0.33% | 12.76% | 24.70% | 7.38 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 255.69 | 248.13 | 254.03 | 245.86 | 233.59 | 182.25 | 189.92 | 174.94 | 200.07 | 194.14 | 201.74 | 198.13 | 194.03 |
| Expenses | 236.93 | 232.26 | 239.57 | 233.84 | 219.16 | 168.79 | 173.22 | 157.69 | 208.33 | 175.20 | 194.09 | 187.48 | 186.64 |
| Operating Profit | 18.76 | 15.87 | 14.46 | 12.02 | 14.43 | 13.46 | 16.70 | 17.25 | -8.26 | 18.94 | 7.65 | 10.65 | 7.39 |
| OPM % | 7.34% | 6.40% | 5.69% | 4.89% | 6.18% | 7.39% | 8.79% | 9.86% | -4.13% | 9.76% | 3.79% | 5.38% | 3.81% |
| Other Income | 5.13 | 2.68 | 9.61 | -6.46 | 231.29 | 2.75 | 0.56 | 3.76 | 8.82 | 3.74 | -6.02 | -6.47 | 21.16 |
| Interest | 16.95 | 15.82 | 16.44 | 16.36 | 11.38 | 19.00 | 19.66 | 20.54 | 22.59 | 20.85 | 23.68 | 19.48 | 18.49 |
| Depreciation | 9.45 | 9.43 | 9.44 | 9.64 | 9.30 | 10.50 | 10.48 | 10.57 | 13.40 | 11.52 | 11.04 | 11.74 | 11.58 |
| Profit before tax | -2.51 | -6.70 | -1.81 | -20.44 | 225.04 | -13.29 | -12.88 | -10.10 | -35.43 | -9.69 | -33.09 | -27.04 | -1.52 |
| Tax % | 38.25% | -11.49% | 59.67% | -5.87% | 65.22% | -1.13% | -5.36% | 34.06% | -44.48% | 55.01% | -9.55% | -39.90% | -431.58% |
| Net Profit | -3.47 | -5.93 | -2.89 | -19.24 | 78.28 | -13.14 | -12.19 | -13.54 | -19.67 | -15.02 | -29.93 | -16.25 | 5.04 |
| EPS in Rs | -2.48 | -2.84 | -2.42 | -7.98 | 19.63 | -3.36 | -3.22 | -2.91 | -4.63 | -2.71 | -6.81 | -3.05 | 4.48 |
Last Updated: May 31, 2025, 6:42 am
Below is a detailed analysis of the quarterly data for Bilcare Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 194.03 Cr.. The value appears to be declining and may need further review. It has decreased from 198.13 Cr. (Dec 2024) to 194.03 Cr., marking a decrease of 4.10 Cr..
- For Expenses, as of Mar 2025, the value is 186.64 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 187.48 Cr. (Dec 2024) to 186.64 Cr., marking a decrease of 0.84 Cr..
- For Operating Profit, as of Mar 2025, the value is 7.39 Cr.. The value appears to be declining and may need further review. It has decreased from 10.65 Cr. (Dec 2024) to 7.39 Cr., marking a decrease of 3.26 Cr..
- For OPM %, as of Mar 2025, the value is 3.81%. The value appears to be declining and may need further review. It has decreased from 5.38% (Dec 2024) to 3.81%, marking a decrease of 1.57%.
- For Other Income, as of Mar 2025, the value is 21.16 Cr.. The value appears strong and on an upward trend. It has increased from -6.47 Cr. (Dec 2024) to 21.16 Cr., marking an increase of 27.63 Cr..
- For Interest, as of Mar 2025, the value is 18.49 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 19.48 Cr. (Dec 2024) to 18.49 Cr., marking a decrease of 0.99 Cr..
- For Depreciation, as of Mar 2025, the value is 11.58 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.74 Cr. (Dec 2024) to 11.58 Cr., marking a decrease of 0.16 Cr..
- For Profit before tax, as of Mar 2025, the value is -1.52 Cr.. The value appears strong and on an upward trend. It has increased from -27.04 Cr. (Dec 2024) to -1.52 Cr., marking an increase of 25.52 Cr..
- For Tax %, as of Mar 2025, the value is -431.58%. The value appears to be improving (decreasing) as expected. It has decreased from -39.90% (Dec 2024) to -431.58%, marking a decrease of 391.68%.
- For Net Profit, as of Mar 2025, the value is 5.04 Cr.. The value appears strong and on an upward trend. It has increased from -16.25 Cr. (Dec 2024) to 5.04 Cr., marking an increase of 21.29 Cr..
- For EPS in Rs, as of Mar 2025, the value is 4.48. The value appears strong and on an upward trend. It has increased from -3.05 (Dec 2024) to 4.48, marking an increase of 7.53.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:03 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,062 | 2,692 | 2,603 | 2,633 | 2,778 | 2,997 | 1,827 | 623 | 845 | 982 | 747 | 788 | 757 |
| Expenses | 2,819 | 2,506 | 2,396 | 2,443 | 2,617 | 2,827 | 1,782 | 572 | 784 | 925 | 708 | 743 | 724 |
| Operating Profit | 243 | 186 | 207 | 190 | 161 | 170 | 45 | 51 | 60 | 57 | 39 | 45 | 33 |
| OPM % | 8% | 7% | 8% | 7% | 6% | 6% | 2% | 8% | 7% | 6% | 5% | 6% | 4% |
| Other Income | 24 | 9 | -87 | 107 | 297 | 59 | 254 | 45 | 44 | 237 | 16 | 12 | 25 |
| Interest | 217 | 236 | 151 | 176 | 249 | 283 | 174 | 76 | 69 | 60 | 82 | 82 | 76 |
| Depreciation | 141 | 191 | 164 | 177 | 416 | 378 | 239 | 46 | 39 | 38 | 45 | 46 | 47 |
| Profit before tax | -91 | -232 | -194 | -56 | -207 | -433 | -114 | -25 | -4 | 196 | -72 | -71 | -65 |
| Tax % | 25% | -7% | -58% | 42% | -4% | 5% | -13% | -55% | 3% | 74% | -18% | -21% | |
| Net Profit | -114 | -216 | -82 | -80 | -199 | -453 | -99 | -11 | -4 | 50 | -59 | -56 | -44 |
| EPS in Rs | -48.14 | -91.76 | -36.04 | -35.91 | -85.43 | -193.28 | -43.97 | -8.95 | -5.35 | 6.39 | -14.12 | -12.23 | -5.43 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -89.47% | 62.04% | 2.44% | -148.75% | -127.64% | 78.15% | 88.89% | 63.64% | 1350.00% | -218.00% | 5.08% |
| Change in YoY Net Profit Growth (%) | 0.00% | 151.51% | -59.60% | -151.19% | 21.11% | 205.78% | 10.74% | -25.25% | 1286.36% | -1568.00% | 223.08% |
Bilcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -12% |
| 5 Years: | -15% |
| 3 Years: | -2% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 14% |
| 3 Years: | 12% |
| TTM: | 27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | -39% |
| 5 Years: | -10% |
| 3 Years: | -5% |
| Last Year: | -5% |
Last Updated: September 5, 2025, 2:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:32 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves | 1,300 | 1,073 | 689 | 590 | 376 | -93 | 85 | 63 | 52 | 507 | 474 | 445 | 430 |
| Borrowings | 2,146 | 2,311 | 2,122 | 2,014 | 2,089 | 2,270 | 707 | 677 | 690 | 639 | 756 | 682 | 672 |
| Other Liabilities | 899 | 933 | 786 | 830 | 913 | 888 | 297 | 300 | 362 | 424 | 314 | 266 | 255 |
| Total Liabilities | 4,368 | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 1,417 | 1,380 |
| Fixed Assets | 2,126 | 1,926 | 2,432 | 2,403 | 2,180 | 2,005 | 534 | 494 | 465 | 1,045 | 1,038 | 949 | 930 |
| CWIP | 262 | 218 | 161 | 149 | 170 | 79 | 0 | 0 | 1 | 1 | 1 | 4 | 7 |
| Investments | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 8 | 11 | 14 |
| Other Assets | 1,979 | 2,196 | 1,026 | 904 | 1,051 | 1,003 | 577 | 570 | 661 | 545 | 521 | 453 | 429 |
| Total Assets | 4,368 | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,112 | 1,064 | 1,127 | 1,593 | 1,568 | 1,417 | 1,380 |
Below is a detailed analysis of the balance sheet data for Bilcare Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 24.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 24.00 Cr..
- For Reserves, as of Sep 2025, the value is 430.00 Cr.. The value appears to be declining and may need further review. It has decreased from 445.00 Cr. (Mar 2025) to 430.00 Cr., marking a decrease of 15.00 Cr..
- For Borrowings, as of Sep 2025, the value is 672.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 682.00 Cr. (Mar 2025) to 672.00 Cr., marking a decrease of 10.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 255.00 Cr.. The value appears to be improving (decreasing). It has decreased from 266.00 Cr. (Mar 2025) to 255.00 Cr., marking a decrease of 11.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,380.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,417.00 Cr. (Mar 2025) to 1,380.00 Cr., marking a decrease of 37.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 930.00 Cr.. The value appears to be declining and may need further review. It has decreased from 949.00 Cr. (Mar 2025) to 930.00 Cr., marking a decrease of 19.00 Cr..
- For CWIP, as of Sep 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 3.00 Cr..
- For Other Assets, as of Sep 2025, the value is 429.00 Cr.. The value appears to be declining and may need further review. It has decreased from 453.00 Cr. (Mar 2025) to 429.00 Cr., marking a decrease of 24.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,380.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,417.00 Cr. (Mar 2025) to 1,380.00 Cr., marking a decrease of 37.00 Cr..
However, the Borrowings (672.00 Cr.) are higher than the Reserves (430.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 241.00 | 184.00 | 205.00 | 188.00 | 159.00 | 168.00 | -662.00 | -626.00 | -630.00 | -582.00 | -717.00 | -637.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 105 | 125 | 35 | 29 | 38 | 38 | 22 | 90 | 95 | 70 | 73 | 55 |
| Inventory Days | 103 | 105 | 108 | 84 | 90 | 82 | 28 | 90 | 83 | 42 | 77 | 80 |
| Days Payable | 76 | 93 | 86 | 81 | 102 | 71 | 35 | 93 | 102 | 77 | 70 | 57 |
| Cash Conversion Cycle | 132 | 137 | 57 | 32 | 25 | 49 | 15 | 88 | 76 | 34 | 80 | 78 |
| Working Capital Days | 114 | 125 | 5 | -11 | -150 | -156 | -2 | -19 | -10 | -10 | 12 | -5 |
| ROCE % | 3% | 1% | 2% | 2% | -8% | -6% | -9% | 3% | 3% | 3% | 1% | 1% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -12.23 | -14.12 | 6.39 | -5.35 | -8.95 |
| Diluted EPS (Rs.) | -12.23 | -14.12 | 6.39 | -5.35 | -8.95 |
| Cash EPS (Rs.) | -4.37 | -5.77 | 37.38 | 14.82 | 14.59 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 199.21 | 274.44 | 161.27 | 68.51 | 69.74 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 199.21 | 274.44 | 298.99 | 68.51 | 69.74 |
| Revenue From Operations / Share (Rs.) | 334.69 | 317.34 | 416.87 | 358.76 | 264.48 |
| PBDIT / Share (Rs.) | 26.79 | 26.19 | 28.45 | 31.86 | 29.45 |
| PBIT / Share (Rs.) | 7.30 | 7.10 | 12.39 | 15.18 | 10.12 |
| PBT / Share (Rs.) | -30.30 | -30.45 | 83.28 | -1.79 | -10.60 |
| Net Profit / Share (Rs.) | -23.86 | -24.86 | 21.32 | -1.85 | -4.74 |
| NP After MI And SOA / Share (Rs.) | -12.23 | -14.12 | 6.39 | -5.35 | -8.95 |
| PBDIT Margin (%) | 8.00 | 8.25 | 6.82 | 8.87 | 11.13 |
| PBIT Margin (%) | 2.18 | 2.23 | 2.97 | 4.23 | 3.82 |
| PBT Margin (%) | -9.05 | -9.59 | 19.97 | -0.50 | -4.00 |
| Net Profit Margin (%) | -7.12 | -7.83 | 5.11 | -0.51 | -1.79 |
| NP After MI And SOA Margin (%) | -3.65 | -4.44 | 1.53 | -1.49 | -3.38 |
| Return on Networth / Equity (%) | -6.14 | -6.67 | 7.29 | -16.75 | -24.42 |
| Return on Capital Employeed (%) | 1.59 | 1.37 | 2.32 | 4.93 | 3.17 |
| Return On Assets (%) | -2.03 | -2.12 | 0.94 | -1.11 | -1.98 |
| Long Term Debt / Equity (X) | 0.96 | 1.09 | 2.49 | 7.14 | 6.14 |
| Total Debt / Equity (X) | 1.43 | 1.52 | 3.09 | 9.18 | 7.85 |
| Asset Turnover Ratio (%) | 0.52 | 0.47 | 0.72 | 0.43 | 0.29 |
| Current Ratio (X) | 1.01 | 1.17 | 1.01 | 1.04 | 1.08 |
| Quick Ratio (X) | 0.66 | 0.87 | 0.76 | 0.70 | 0.75 |
| Inventory Turnover Ratio (X) | 7.06 | 5.47 | 6.44 | 3.73 | 3.31 |
| Interest Coverage Ratio (X) | 0.76 | 0.75 | 1.12 | 1.09 | 0.91 |
| Interest Coverage Ratio (Post Tax) (X) | 0.39 | 0.36 | -1.94 | 0.51 | 0.49 |
| Enterprise Value (Cr.) | 991.34 | 998.83 | 881.91 | 900.48 | 834.43 |
| EV / Net Operating Revenue (X) | 1.26 | 1.34 | 0.89 | 1.07 | 1.34 |
| EV / EBITDA (X) | 15.72 | 16.20 | 13.16 | 12.01 | 12.03 |
| MarketCap / Net Operating Revenue (X) | 0.27 | 0.17 | 0.10 | 0.19 | 0.21 |
| Price / BV (X) | 0.46 | 0.26 | 0.49 | 2.19 | 1.57 |
| Price / Net Operating Revenue (X) | 0.27 | 0.17 | 0.10 | 0.19 | 0.21 |
| EarningsYield | -0.13 | -0.25 | 0.14 | -0.07 | -0.15 |
After reviewing the key financial ratios for Bilcare Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -12.23. This value is below the healthy minimum of 5. It has increased from -14.12 (Mar 24) to -12.23, marking an increase of 1.89.
- For Diluted EPS (Rs.), as of Mar 25, the value is -12.23. This value is below the healthy minimum of 5. It has increased from -14.12 (Mar 24) to -12.23, marking an increase of 1.89.
- For Cash EPS (Rs.), as of Mar 25, the value is -4.37. This value is below the healthy minimum of 3. It has increased from -5.77 (Mar 24) to -4.37, marking an increase of 1.40.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 199.21. It has decreased from 274.44 (Mar 24) to 199.21, marking a decrease of 75.23.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 199.21. It has decreased from 274.44 (Mar 24) to 199.21, marking a decrease of 75.23.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 334.69. It has increased from 317.34 (Mar 24) to 334.69, marking an increase of 17.35.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 26.79. This value is within the healthy range. It has increased from 26.19 (Mar 24) to 26.79, marking an increase of 0.60.
- For PBIT / Share (Rs.), as of Mar 25, the value is 7.30. This value is within the healthy range. It has increased from 7.10 (Mar 24) to 7.30, marking an increase of 0.20.
- For PBT / Share (Rs.), as of Mar 25, the value is -30.30. This value is below the healthy minimum of 0. It has increased from -30.45 (Mar 24) to -30.30, marking an increase of 0.15.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -23.86. This value is below the healthy minimum of 2. It has increased from -24.86 (Mar 24) to -23.86, marking an increase of 1.00.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -12.23. This value is below the healthy minimum of 2. It has increased from -14.12 (Mar 24) to -12.23, marking an increase of 1.89.
- For PBDIT Margin (%), as of Mar 25, the value is 8.00. This value is below the healthy minimum of 10. It has decreased from 8.25 (Mar 24) to 8.00, marking a decrease of 0.25.
- For PBIT Margin (%), as of Mar 25, the value is 2.18. This value is below the healthy minimum of 10. It has decreased from 2.23 (Mar 24) to 2.18, marking a decrease of 0.05.
- For PBT Margin (%), as of Mar 25, the value is -9.05. This value is below the healthy minimum of 10. It has increased from -9.59 (Mar 24) to -9.05, marking an increase of 0.54.
- For Net Profit Margin (%), as of Mar 25, the value is -7.12. This value is below the healthy minimum of 5. It has increased from -7.83 (Mar 24) to -7.12, marking an increase of 0.71.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -3.65. This value is below the healthy minimum of 8. It has increased from -4.44 (Mar 24) to -3.65, marking an increase of 0.79.
- For Return on Networth / Equity (%), as of Mar 25, the value is -6.14. This value is below the healthy minimum of 15. It has increased from -6.67 (Mar 24) to -6.14, marking an increase of 0.53.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 10. It has increased from 1.37 (Mar 24) to 1.59, marking an increase of 0.22.
- For Return On Assets (%), as of Mar 25, the value is -2.03. This value is below the healthy minimum of 5. It has increased from -2.12 (Mar 24) to -2.03, marking an increase of 0.09.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.96. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 0.96, marking a decrease of 0.13.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.43. This value exceeds the healthy maximum of 1. It has decreased from 1.52 (Mar 24) to 1.43, marking a decrease of 0.09.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.52. It has increased from 0.47 (Mar 24) to 0.52, marking an increase of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 1.5. It has decreased from 1.17 (Mar 24) to 1.01, marking a decrease of 0.16.
- For Quick Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has decreased from 0.87 (Mar 24) to 0.66, marking a decrease of 0.21.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.06. This value is within the healthy range. It has increased from 5.47 (Mar 24) to 7.06, marking an increase of 1.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 3. It has increased from 0.75 (Mar 24) to 0.76, marking an increase of 0.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 3. It has increased from 0.36 (Mar 24) to 0.39, marking an increase of 0.03.
- For Enterprise Value (Cr.), as of Mar 25, the value is 991.34. It has decreased from 998.83 (Mar 24) to 991.34, marking a decrease of 7.49.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 1.34 (Mar 24) to 1.26, marking a decrease of 0.08.
- For EV / EBITDA (X), as of Mar 25, the value is 15.72. This value exceeds the healthy maximum of 15. It has decreased from 16.20 (Mar 24) to 15.72, marking a decrease of 0.48.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 24) to 0.27, marking an increase of 0.10.
- For Price / BV (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 24) to 0.46, marking an increase of 0.20.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from 0.17 (Mar 24) to 0.27, marking an increase of 0.10.
- For EarningsYield, as of Mar 25, the value is -0.13. This value is below the healthy minimum of 5. It has increased from -0.25 (Mar 24) to -0.13, marking an increase of 0.12.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bilcare Ltd:
- Net Profit Margin: -7.12%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.59% (Industry Average ROCE: 12.76%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -6.14% (Industry Average ROE: 24.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.39
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.66
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 48.49)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.43
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -7.12%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Packaging & Containers | 1028, Shiroli, Rajgurunagar, Pune Maharashtra 410505 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Shreyans Bhandari | Chairman & Managing Director |
| Ms. Kavita Bhansali | Executive Director |
| Mr. Rajesh Devene | Independent Director |
| Mrs. Madhuri Vaidya | Independent Director |
| Ms. Alka Sagar | Independent Director |
FAQ
What is the intrinsic value of Bilcare Ltd?
Bilcare Ltd's intrinsic value (as of 24 December 2025) is 131.82 which is 62.54% higher the current market price of 81.10, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 191 Cr. market cap, FY2025-2026 high/low of 116/52.4, reserves of ₹430 Cr, and liabilities of 1,380 Cr.
What is the Market Cap of Bilcare Ltd?
The Market Cap of Bilcare Ltd is 191 Cr..
What is the current Stock Price of Bilcare Ltd as on 24 December 2025?
The current stock price of Bilcare Ltd as on 24 December 2025 is 81.1.
What is the High / Low of Bilcare Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bilcare Ltd stocks is 116/52.4.
What is the Stock P/E of Bilcare Ltd?
The Stock P/E of Bilcare Ltd is .
What is the Book Value of Bilcare Ltd?
The Book Value of Bilcare Ltd is 193.
What is the Dividend Yield of Bilcare Ltd?
The Dividend Yield of Bilcare Ltd is 0.00 %.
What is the ROCE of Bilcare Ltd?
The ROCE of Bilcare Ltd is 1.10 %.
What is the ROE of Bilcare Ltd?
The ROE of Bilcare Ltd is 5.58 %.
What is the Face Value of Bilcare Ltd?
The Face Value of Bilcare Ltd is 10.0.